Just the Facts on Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics, Inc. (FOLD) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $14.24, down from yesterday’s close by -2.73%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

No amount of research is complete without a bird’s eye view of the financial data. Amicus Therapeutics, Inc. (FOLD) currently trades with a market capitalization of $2.30 Billion.



The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For FOLD, the company currently has $37.74 Million of cash on the books. You can get a sense of how sustainable that is by a levered free cash flow of $-168.26 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $-0.31 on a per share basis this quarter. Perhaps, that suggests something about why 80.62% of the outstanding share supply is held by institutional investors.

Technical Analysis

It’s important to check the technicals to get a sense of how FOLD has been acting. Looking at the stock’s movement on the chart, Amicus Therapeutics, Inc. recorded a 52-week high of $16.60. It is now trading 2.36% off that level. The stock is trading $13.91 its 50-day moving average by -0.33%. The stock carved out a 52-week low down at $4.41.

In recent action, Amicus Therapeutics, Inc. (FOLD) has made a move of -4.56% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 19.52, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 19.34% with $161.40 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of FOLD.

SHARE
Previous articleDrilling Down Into Celsion Corporation (CLSN)
Next articleTaking a Look at the Data Behind Social Reality, Inc. (SRAX)